Drug Profile
Research programme: small molecule therapeutics - Action Pharma
Alternative Names: AP 1102; AP 1130; AP 1170; AP 405; AP11-seriesLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Action Pharma
- Class Small molecules
- Mechanism of Action Melanocortin receptor agonists; Melanocortin receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Atopic dermatitis; Inflammation; Obesity; Type 2 diabetes mellitus
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Atopic-dermatitis in Denmark (Topical)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Inflammation in Denmark (PO)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Obesity in Denmark (PO)